SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Opinion

Raging bull' - Vaccines don’t cause autism and saying otherwise costs lives

Vaccines do not cause autism and people who say otherwise are wrong.

Momenta says Pfizer will fix plant but reiterates that Glatopa 40mg ANDA delay likely

Momenta Pharmaceuticals has reiterated its belief that problems at a US Pfizer plant mean the FDA is unlikely to reach a decision on its 40mg version of Teva’s Copaxone before April.

Modus raises cash for Ph II trial of Sickle Cell drug in EU, Middle East and Caribbean

Modus Therapeutics AB has raised an additional 32m SEK (£2.85m) for its Phase II trial for pain crises in Sickle Cell Disease, running in the Caribbean, Middle East and Europe.

Cancer drug plant likely source of radio isotope detected across Europe say experts

A radiopharmaceuticals plant is the most likely source of the radioactive iodine-131 detected in several countries in recent weeks according to experts.

Granules to expand Indian API plants and US dosage form site

Granules India will build an API production facility in Bonthapally, Telangana and expand other manufacturing sites in a project backed by the Word Bank. 

AmpTec looking to achieve full GMP compliance for APIs

AmpTec GmbH is in the process of achieving full GMP compliance for API manufacturers in order to expand its offerings into the clinical space.

Pfizer hit with US FDA warning at Kansas generic Copaxone site

The US FDA has issued a warning letter to the former Hospira fill and finish facility in McPherson, Kansas – now part of Pfizer’s contract manufacturing business CentreOne.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...

Products

Producing the perfect soft gel
Leading manufacturer of gelatine and collagen peptides